methyl 5-(tributylstannyl)thiophene-2-carboxylate | 157025-32-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: methyl 5-(tributylstannyl)thiophene-2-carboxylate
• 英文别名: 5-tributylstannanylthiophene-2-carboxylic acid methyl ester；2-Thiophenecarboxylic acid, 5-(tributylstannyl)-, methyl ester；methyl 5-tributylstannylthiophene-2-carboxylate
• CAS: 157025-32-6
• 化学式: C₁₈H₃₂O₂SSn
• 分子量: 431.227
• InChiKey: JKIKBEDUDKMKTF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.59
• 重原子数：
  22
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.72
• 拓扑面积：
  54.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 5-(tributylstannyl)thiophene-2-carboxylate 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 palladium 10% on activated carbon 、 氢气 、 cesium fluoride 、 copper(l) chloride 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 反应 22.0h， 生成 methyl 5-(2-ethylpyridin-4-yl)thiophene-2-carboxylate
  参考文献：
  名称：

  [EN] 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I
  [FR] DÉRIVÉS 3-OXO-TÉTRAHYDRO-FURO [3,2-B] PYRROL -4 (5H)-YL)

  摘要：

  这项发明涉及作为双重CatS/K抑制剂的酰胺氧代四氢-2H-呋喃[3.2-b]吡咯-4(5H)-基)衍生物，以及含有这些化合物的药物组合物，还涉及这些化合物用于治疗和/或预防疼痛以及其他疾病和/或紊乱。

  公开号：

  WO2015161928A1
• 作为产物：
  描述：

  2-噻吩甲酸 在 氯化亚砜 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 6.0h， 生成 methyl 5-(tributylstannyl)thiophene-2-carboxylate
  参考文献：
  名称：

  Synergic effect of unsaturated inner bridges and polymorphism for tuning the optoelectronic properties of 2,3-thieno(bis)imide based materials

  摘要：

  我们报道了三种新的多态2,3-噻吩（双）亚胺分子材料（NTE、NTI和NTA）的合成、结构-性能关系研究。

  DOI：

  10.1039/c4tc01792g

文献信息

• [EN] BIS(HETERO)ARYL CARBOXAMIDE DERIVATIVES FOR USE AS PGI2 ANTAGONISTS<br/>[FR] DERIVES DE BIS(HETERO)ARYLE CARBOXAMIDE DESTINES A ETRE UTILISES EN TANT QU'ANTAGONISTES DE LA PG12
  申请人：BAYER HEALTHCARE AG

  公开号：WO2004069805A1

  公开（公告）日：2004-08-19

  The present invention relates to aryl or heteroaryl amido alkane derivatives of formula (I) wherein R6 represents carboxy or tetrazolyl, which are useful as an active ingredient of pharmaceutical preparations. The aryl or heteroaryl amido alkanes of the present invention have PGI2 antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with PGI2 activity.Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity.The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension;hemophilia and hemorrhage; and inflammation, since the diseases also relate to PGI2.

  本发明涉及式(I)的芳基或杂环芳基酰胺烷基衍生物，其中R6代表羧基或四唑基，其作为药物制剂的活性成分是有用的。本发明的芳基或杂环芳基酰胺烷基具有PGI2拮抗活性，可用于预防和治疗与PGI2活性相关的疾病。这些疾病包括泌尿系统疾病或障碍，如：膀胱出口梗阻、膀胱过度活跃、尿失禁、膀胱逼尿肌过度反射、膀胱逼尿肌不稳定、膀胱容量减少、排尿频率增加、急迫性尿失禁、压力性尿失禁、膀胱高反应性、良性前列腺增生（BPH）、前列腺炎、尿频、夜尿、尿急、盆腔过敏、尿道炎、盆腔疼痛综合征、前列腺疼痛综合征、膀胱炎或特发性膀胱过敏。本发明的化合物还可用于治疗疼痛，包括但不限于炎症性疼痛、神经病性疼痛、急性疼痛、慢性疼痛、牙痛、经前疼痛、内脏疼痛、头痛等；低血压；血友病和出血；以及炎症，因为这些疾病也与PGI2有关。
• [EN] 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II<br/>[FR] DÉRIVÉS II DU 3-OXO-TÉTRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YLE
  申请人：GRUENENTHAL GMBH

  公开号：WO2015161924A1

  公开（公告）日：2015-10-29

  The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors exhibiting a pronounced CatK-inhibition, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

  这项发明涉及作为双重CatS/K抑制剂的酰胺氧代四氢-2H-呋喃[3.2-b]吡咯-4(5H)-基)衍生物，这些衍生物表现出明显的CatK抑制作用，以及含有这些化合物的药物组合物，以及这些化合物用于治疗和/或预防疼痛和其他疾病和/或紊乱。
• Porphyrin sensitizers involving a fluorine-substituted benzothiadiazole as auxiliary acceptor and thiophene as π bridge for use in dye-sensitized solar cells (DSSCs)
  作者：Jingrui Jie、Qinqin Xu、Guang Yang、Yaqing Feng、Bao Zhang

  DOI：10.1016/j.dyepig.2019.107984

  日期：2020.3

  TH-0F, TH-1F and TH-2F with a benzothiadiazole (BTD) unit bearing no fluorine, one fluorine and two fluorine atoms, respectively, as the auxiliary acceptor and thiophene as the π bridge were designed and synthesized for use in dye-sensitized solar cells (DSSCs). The influence of fluorine atom and thiophene unit on the photophysical and photochemical properties of the sensitizers was investigated. It

  三种“供体-受体-π桥-受体”（D–A–π–A）型卟啉锌敏化剂TH-0F，TH-1F和TH-2F，苯并噻二唑（BTD）单元不含氟，一种氟和两种设计并合成了分别用于染料敏化太阳能电池（DSSC）的氟原子作为辅助受体，并将噻吩作为π桥。研究了氟原子和噻吩单元对敏化剂光物理和光化学性质的影响。结果表明，三种基于敏化剂的器件的光子至电流转换效率（PCE）依次为TH-2F  >  TH-1F  >  TH-0F，其中PCE最高达到6.98％。基于TH-2F的设备。为了进一步了解TH系列染料的分子结构，进行了密度泛函（DFT）计算。结果表明，氟原子的强吸电子能力，以及辅助受体和噻吩之间的分子内相互作用，优化了电子构型，从而促进了分子内电荷转移效率并最终改善了相应器件的性能。
• Bis (hetero) aryl carboxamide derivatives for use as PG12 antagonists
  申请人：Murata Toshiki

  公开号：US20060247260A1

  公开（公告）日：2006-11-02

  This invention relates to aryl or heteroaryl amido alkane derivatives of formula (I) in which Ar 1 and Ar 2 independently represent phenyl or a 5 or 6-membered heteroaromatic ring, R 6 represents carboxyl or tetrazolyl, and the remaining variables are as defined in the text and claims, which are useful as an active ingredient of pharmaceutical preparations. The aryl or heteroaryl amido alkanes of the present invention have PGI2 antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with PGI2 activity. Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity. The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension;hemophilia and hemorrhage; and inflammation, since the diseases also relate to PGI2.

  本发明涉及公式（I）中的芳基或杂环芳基酰胺烷衍生物，其中Ar1和Ar2分别表示苯基或5或6成员杂环芳基环，R6表示羧基或四唑基，其余变量如文本和权利要求所定义，可用作药物制剂的活性成分。本发明的芳基或杂环芳基酰胺烷具有PGI2拮抗活性，可用于预防和治疗与PGI2活性相关的疾病。这些疾病包括以下泌尿系统疾病或障碍：膀胱出口梗阻，过度活动的膀胱，尿失禁，膀胱平滑肌反射亢进，膀胱平滑肌不稳定，膀胱容量减少，排尿频率，急迫性尿失禁，压力性尿失禁，膀胱高反应性，良性前列腺增生（BPH），前列腺炎，尿频，夜尿，尿急，盆腔过敏，尿道炎，盆腔疼痛综合征，前列腺疼痛，膀胱炎或特发性膀胱过敏。本发明化合物还可用于治疗疼痛，包括但不限于炎症性疼痛，神经病理性疼痛，急性疼痛，慢性疼痛，牙痛，经前痛，内脏疼痛，头痛等；低血压；血友病和出血；以及炎症，因为这些疾病也与PGI2有关。
• 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I
  申请人：GRÜNENTHAL GMBH

  公开号：US20150307507A1

  公开（公告）日：2015-10-29

  The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors. to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

  本发明涉及氨基酰氧代四氢-2H-呋喃[3.2-b]吡咯-4(5H)-基衍生物，作为双重CatS/K抑制剂，以及含有这些化合物的制药组合物，以及这些化合物在治疗和/或预防疼痛和其他疾病和/或紊乱方面的用途。